Partners & Collaborations

JPT Peptide Technologies is an established partner in research projects worldwide. Our network combines partners within universities, research organizations and industry that value JPT’s unmatched peptide synthesis power, R&D specialists and high quality standards according to DIN ISO 9001:2015 certification and GCLP regulations.

JPT offers its services and contract research and development project participation in flexible business arrangements.

Our Business Models are:

  • Fee-for-service projects
  • FTE based and milestone driven collaboration projects
  • Shared risk, partnered development projects
  • Participation on publicly granted R&D projects (SME qualification)

Our project partners

Our Track Record

JPT has run several successful projects in different scientific fields:

Immunotherapy & Vaccines
  • Peptide selection and synthesis for individualized neo-epitope based vaccination strategies
  • Peptide pool design and synthesis for adoptive cell transfer therapy
  • Design of comprehensive peptide libraries for companion diagnostics and treatment
  • Identification of serological predictive, prognostic, and surrogate biomarkers
  • Proteome-spanning vaccine target discovery
  • Deep T-cell epitope discovery
  • Development of next generation standards for targeted proteomics
  • Characterization of specificity profiles for proteins and protein families
  • Design and synthesis of peptide libraries for proteome wide detection and quantification of proteins
  • Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
  • Discovery of proteotypic peptide markers for functional proteomics
  • Identification of epigenetic states of proteins and characterization of enzymatic alterations
Drug Discovery
  • Design and production of screening libraries, peptides and peptidomimetics
  • Identification and optimization of agonistic and antagonistic ligands
  • Identification and optimization of affinity ligands
  • Identification and optimization of stabilizing peptides as excipients
  • Development of surrogate bioassays for antigen-free detection of therapeutic protein
  • Substrate identification and optimization for several orphan enzymes for screening assays
website logo EFRE landscape small
website logo biontech
website logo zellnet

Check our list of products, click and go.

Get a quote